Literature DB >> 7535829

Antibodies against viral nonstructural proteins in response to infection with poliovirus.

E Ehrenfeld1, D Brown, X Y Jia, D F Summers.   

Abstract

Sera from recent and past cases of poliomyelitis as well as from healthy subjects vaccinated with live attenuated poliovirus, all contain antibodies to poliovirus nonstructural proteins. Reactivity of these antisera with nonstructural protein antigens present in virus-infected HeLa cells or translated from cDNA transcripts in rabbit reticulocyte lysates was sometimes sensitive to denaturation of the antigens. The finding of antibodies to nonstructural proteins of poliovirus and other viruses should have applications in the development of diagnostic assays for virus infection and may have implications for future vaccine design.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535829     DOI: 10.1093/infdis/171.4.845

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Combined cell culture enzyme-linked immunosorbent assay for quantification of poliovirus neutralization- relevant antibodies.

Authors:  A F Wahby
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

Review 2.  Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity.

Authors:  M K Slifka; R Ahmed
Journal:  Trends Microbiol       Date:  1996-10       Impact factor: 17.079

3.  Epitope mapping of monoclonal antibodies raised to recombinant Mengo 3D polymerase.

Authors:  H Duque; A C Palmenberg
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

4.  Immunization with nonstructural proteins promotes functional recovery of alphavirus-infected neurons.

Authors:  M D Gorrell; J A Lemm; C M Rice; D E Griffin
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Mengo virus 3C proteinase: recombinant expression, intergenus substrate cleavage and localization in vivo.

Authors:  D J Hall; A C Palmenberg
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.